BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6296001)

  • 1. Ceftizoxime treatment of infection in neutropenic patients with malignancies.
    Lawson RD; Baskin RC
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():159-65. PubMed ID: 6296001
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftizoxime in the treatment of infections in patients with cancer.
    Fainstein V; Bolivar R; Elting L; Valdivieso M; Bodey GP
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():167-73. PubMed ID: 6296002
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of ceftizoxime and related compounds in animals models of infection.
    Actor P; Grappel SF
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():81-9. PubMed ID: 6296033
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of ceftizoxime in the treatment of critically ill patients infected with multiply antibiotic resistant bacteria.
    Scully BE; Neu HC
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():141-50. PubMed ID: 6295999
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of ceftizoxime in the treatment of paediatric infections.
    Shikuma CM; Cable DC; Edralin G; Overturf GD
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():293-5. PubMed ID: 6296023
    [No Abstract]   [Full Text] [Related]  

  • 6. Ceftizoxime vs. cefotaxime--a comparative randomized multicenter study.
    Segev S; Kitzes R; Rubinstein E; Pitlik S; Samra Y; Shenkman L; Weinberg M
    Isr J Med Sci; 1988 Aug; 24(8):410-4. PubMed ID: 3045049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ceftizoxime in acute peritonitis.
    Lou MA; Chen DF; Bansal M; Balasubramaniam S; Thadepalli H
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():183-9. PubMed ID: 6296004
    [No Abstract]   [Full Text] [Related]  

  • 8. Ceftizoxime in moderate-to-severe infections.
    Johnson ES; Smith LG
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():151-7. PubMed ID: 6296000
    [No Abstract]   [Full Text] [Related]  

  • 9. Ceftizoxime compared with cefamandole for treatment of soft tissue infections.
    Mills J; Slutkin G; Klein D; Schecter W
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():273-9. PubMed ID: 6296020
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of a combination of cefotaxime, tobramycin and vancomycin as antibiotic therapy for neutropenia.
    Brunet F; Lanore JJ; Dhainaut JF; Dreyfus F; Huyghebaert MF; Varet B; Monsallier JF
    Drugs; 1988; 35 Suppl 2():195. PubMed ID: 3396480
    [No Abstract]   [Full Text] [Related]  

  • 11. Monotherapy with pefloxacin in neutropenic febrile patients.
    Daniels-Bosman MS; Beun GD; Debrus-Palmans LL; Blijham GH
    Chemioterapia; 1987 Jun; 6(2 Suppl):410. PubMed ID: 3509459
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical effects of ceftizoxime and latamoxef on infections in acute leukemia].
    Kohi F; Ohmoto E; Endo Y; Oda Y; Fujimoto S; Uchida K; Takaoka K; Hara M; Lai M; Takahashi I
    Jpn J Antibiot; 1983 Jul; 36(7):1645-52. PubMed ID: 6317909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease.
    Gaya H; Klastersky J; Schimpff SC; Tattersall MH
    Eur J Cancer (1965); 1975 Aug; 11suppl():1-4. PubMed ID: 767118
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of ceftizoxime in neonates.
    Yamauchi T; Hill DE; Steele RW
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():297-301. PubMed ID: 6296024
    [No Abstract]   [Full Text] [Related]  

  • 15. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
    Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V
    Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies of the efficacy and tolerance of cefotaxime, ceftizoxime and ceftriaxone in patients with complicated urinary tract infections].
    Westenfelder M; Pelz K
    Infection; 1983; 11(6):296-301. PubMed ID: 6321356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftizoxime plus ticarcillin: double beta-lactam therapy for infections in cancer patients.
    Rolston KV; Jones PG; Fainstein V; Elting L; Bodey GP
    J Antimicrob Chemother; 1987 Mar; 19(3):367-71. PubMed ID: 3471752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of ceftizoxime in treating infections due to organisms resistant to other antibiotics.
    Neu HC
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():193-9. PubMed ID: 6296006
    [No Abstract]   [Full Text] [Related]  

  • 19. [Infections in neutropenic children with neoplasms. Case series contribution].
    Giacchino M; Artino RM; Miniero R; Grazia G; Vivalda M; Dotti G; Mattirolo F; Madon E
    Minerva Pediatr; 1988 Jun; 40(6):339-44. PubMed ID: 3054471
    [No Abstract]   [Full Text] [Related]  

  • 20. Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.
    Hathorn JW; Rubin M; Pizzo PA
    Antimicrob Agents Chemother; 1987 Jul; 31(7):971-7. PubMed ID: 3310871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.